JWJason White

Jason White

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jason White has a total of 136 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    African Pan Genome Contigs Expose Biologically Relevant Sequence Still Hidden from Human Reference Frameworks

    by Rachel Martini, Abdulfatai Tijjani, Kyriaki Founta, Daniel Cha, Alexandria Awai, Sebastian Maurice, Jason A. White, Christopher E. Mason, Isidro Cortes-Ciriano, Nicolas Robine, et al.

    Human reference genomes underpin biomedical discovery but remain incomplete and biased toward European populations, constraining interpretation of genetic variation in underrepresented populations. Here we characterize African Pan Genome (APG) contigs totaling 296.5 Mb to define the sequence and functional landscape of genomic regions absent from current references. Most contigs align to the telomere-to-telomere (T2T-CHM13) genome and across 47 haplotype-resolved Human Pangenome Reference Consortium (HPRC) assemblies, with T2T-CHM13 placements enriched in centromeric and satellite repeats and overlapping 373 genes, including disease-associated loci. Mapping across HPRC assemblies revealed ancestry-associated contig enrichment, particularly in African genomes. Notably, 742 contigs remained unmapped under both stringent and relaxed criteria. These sequences are largely nonrepetitive and exhibit strong functional potential, including predicted protein-coding genes, CpG islands and transcriptional activity. Together, these results demonstrate that functionally relevant, ancestry-enriched genomic sequences remain absent from current references, with important implications for disease variant interpretation and precision medicine.

  • Open Access

    TABLE 1 from African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A

    by Manjunath Siddappa, Shahid Hussain, Sajad A. Wani, Jason White, Hancong Tang, Jaimie S. Gray, Hedieh Jafari, Hsu-Chang Wu, Mark D. Long, Isra Elhussin, et al.

    Overlap of BAZ1A-dependent 1α,25(OH)2D3-regulated gene expression with genes annotated to 1α,25(OH)2D3-regulated NF regions and VDR-binding sites

  • Open Access

    TABLE 2 from African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A

    by Manjunath Siddappa, Shahid Hussain, Sajad A. Wani, Jason White, Hancong Tang, Jaimie S. Gray, Hedieh Jafari, Hsu-Chang Wu, Mark D. Long, Isra Elhussin, et al.

    Percentage overlap of either serum 25(OH)D3 vitamin D3-regulated or obesity-regulated gene expression in prostate tumors from AA patients with genes annotated by 1α,25(OH)2D3-regulated NF regions and/or VDR ChIP-seq

  • Open Access

    FIGURE 4 from African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A

    by Manjunath Siddappa, Shahid Hussain, Sajad A. Wani, Jason White, Hancong Tang, Jaimie S. Gray, Hedieh Jafari, Hsu-Chang Wu, Mark D. Long, Isra Elhussin, et al.

    1α,25(OH)2D3-dependent RNA- and small RNA-Seq in AA and EA cell lines. A and B, Basal and 1α,25(OH)2D3-stimulated (100 nmol/L, 8 hours) RNA-seq was undertaken in triplicate in HPr1AR, LNCaP, RC43N, and RC43T. FASTQ files were QC processed, aligned to hg38 (Rsubread), and processed with limma-voom and edgeR workflow to identify significant DEGs (logPV > 1 and absFC > 0.37) are illustrated on Volcano plots with top DEGs illustrated. C, GSEAs (Chemical Perturbations in GSEA) was undertaken and the terms identified and visualized where the NES was in the opposite direction are visualized in RC43N and RC43T.

  • Open Access

    FIGURE 6 from African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A

    by Manjunath Siddappa, Shahid Hussain, Sajad A. Wani, Jason White, Hancong Tang, Jaimie S. Gray, Hedieh Jafari, Hsu-Chang Wu, Mark D. Long, Isra Elhussin, et al.

    VDR cistrome-transciptome relationships in prostate cancer. A, A cohort of 7 AA patients with prostate cancer with conserved African genomic ancestry and 16 EA patients with prostate cancer were treated with vitamin D3 (4,000 IU daily), and RNA-seq undertaken on the tumors following radical prostatectomy, as we reported previously (6). Significantly differentially regulated genes in the AA prostate cancer group (there were no DEGs in the EA prostate cancer group) were overlapped with genes annotated to ATAC-seq or ChIP-seq regions within 100 kb. The Volcano plot of the DEGs for the response in AA men (left), or comparing basal AA to EA prostate cancer (right) and annotated with genes that are VDR bound and/or 1α,25(OH)2D3-dependent NF region annotated genes. B, RNA-seq was undertaken in tumors from a cohort of 57 AA and 18 EA patients who underwent radical prostatectomy at Northwestern Medical Center. Tumor-specific significant DEGs were identified for deficient serum 25(OH)D3 (serum 25(OH)D3 levels < 12 ng/mL; low; left) or obesity (BMI > 30; O; right). In each case BMI or 25(OH)D3 levels were kept as a continuous variable, respectively. The DEGs for 25(OH)D3 deficiency (left) of obesity (right) in the AA prostate cancer group (there were no DEGs in the EA prostate cancer group) were overlapped with genes annotated to ATAC-seq or ChIP-seq regions within 100 kb. C, Partial correlation analyses in equal numbers of AA or EA tumors (n = 36) from Northwestern cohort was undertaken between VDR and either AA or EA ChIP-seq annotated genes in AA and EA tumors respectively considering the impact of the indicated coregulators. The change in the correlation (delta.corr) was calculated as the difference between the Pearson correlation and Pearson partial correlations between VDR and these target genes and each of the indicated coregulators.

  • Open Access

    FIGURE 2 from African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A

    by Manjunath Siddappa, Shahid Hussain, Sajad A. Wani, Jason White, Hancong Tang, Jaimie S. Gray, Hedieh Jafari, Hsu-Chang Wu, Mark D. Long, Isra Elhussin, et al.

    VDR ATAC-seq in AA and EA cell lines. A, ATAC-seq was undertaken in triplicate in HPr1AR, LNCaP, RC43N, and RC43T following 1α,25(OH)2D3 treatment (100 nmol/L, 4 hours) or vehicle control. FASTQ files were QC processed, aligned to hg38 (Rsubread), sorted and duplicates removed before further processing with ATACseqQC to generate nucleosome free and mononucleosome regions. Differential enrichment of regions was measured with csaw and the significantly different regions (Padj < 0.1) were then intersected to generate the Venn diagrams of overlapping regions by a minimum of 1 bp (ChIPpeakAnno). B, Motif enrichment in NF regions was undertaken with Homer and ranked by significance to visualize in descending significance. C, Frequency of enriched motifs by TF families’ class. D, Enrichment of circadian rhythm TFs.

  • Open Access

    FIGURE 1 from African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A

    by Manjunath Siddappa, Shahid Hussain, Sajad A. Wani, Jason White, Hancong Tang, Jaimie S. Gray, Hedieh Jafari, Hsu-Chang Wu, Mark D. Long, Isra Elhussin, et al.

    Expression of VDR and responses to 1α,25(OH)2D3 in AA and EA cell lines. A, Western immunoblot measurements of VDR levels after 1α,25(OH)2D3 treatment (100 nmol/L, 24 hours) or vehicle control. B, RIME analyses of VDR in the indicated cells (in quadriplicates) and significantly different proteins were identified using an edgeR workflow. Volcano plots depicting enrichment levels, compared with IgG controls, between the indicated cells in basal or 1α,25(OH)2D3-stimulated conditions (100 nmol/L, 4 hours). Significant (Padj < 0.1) differentially and uniquely enriched proteins in each cell and treatment condition were classified either as a CoA, CoR, Mixed, or TF. C, The most altered components of the VDR complex were established in RC43T compared with LNCaP, and RC43N with HPr1AR, and then the delta between these comparisons were identified and ranked.

  • Open Access

    FIGURE 3 from African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A

    by Manjunath Siddappa, Shahid Hussain, Sajad A. Wani, Jason White, Hancong Tang, Jaimie S. Gray, Hedieh Jafari, Hsu-Chang Wu, Mark D. Long, Isra Elhussin, et al.

    VDR ChIP-seq in AA and EA cell lines. A, Basal and 1α,25(OH)2D3-stimulated (100 nmol/L, 6 hours) VDR ChIP-seq was undertaken in triplicate in HPr1AR, LNCaP, RC43N, and RC43T. FASTQ files were QC processed, aligned to hg38 (Rsubread), sorted and duplicates removed before differential enrichment of regions was measured with csaw and the significantly different regions compared with IgG controls (Padj < 0.1) were then intersected to generate the Venn diagrams of overlapping regions by a minimum of 1 bp (ChIPpeakAnno). B, Significantly differentially enriched motifs were identified by Homer and nuclear receptors are illustrated. C, Changes in motif enrichment were calculated (delta) and ranked by significance for visualization.

  • Open Access

    FIGURE 5 from African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A

    by Manjunath Siddappa, Shahid Hussain, Sajad A. Wani, Jason White, Hancong Tang, Jaimie S. Gray, Hedieh Jafari, Hsu-Chang Wu, Mark D. Long, Isra Elhussin, et al.

    The impact of BAZ1A on expression of VDR-dependent gene networks. A, Altered BAZ1A and SMARCA5 expression in AA prostate cancer was identified in TCGA prostate cancer cohort by comparing EA and AA tumors and considering status of TMPRSS2 translocations. B, The blot used for Fig. 1A (cells treated with 1α,25(OH)2D3 (100 nmol/L, 24 hours) or vehicle control and total protein isolated) was stripped and reprobed with antibodies toward BAZ1A and SMARCA5. C, Unique DEGs in cells with restored expression of BAZ1A. D, BAZ1A-dependent DEGs enhanced inflammatory responses and repressed MYC networks. E, Comparable and divergent GSEA enrichment in BAZ1A-dependent DEGS in RC43N and RC43T that were different from the direction of enrichment in the parental cells.

  • Whole‐exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways

    by Jason A. White, Ernest T. Kaninjing, Kayode A. Adeniji, Paul Jibrin, John O. Obafunwa, Chidiebere N. Ogo, Faruk Mohammed, Ademola Popoola, Omolara A. Fatiregun, Olabode P. Oluwole, et al.

    Background: Through whole‐exome sequencing of 60 formalin‐fixed paraffin‐embedded Nigerian (NGRn) benign prostatic hyperplasia (BPH) samples, we identified germline and somatic alterations in apoptotic pathways impacting BPH development and progression. Prostate enlargement is a common occurrence in male aging; however, this enlargement can lead to lower urinary tract symptoms that negatively impact quality of life. This impact is disproportionately present in men of African ancestry. BPH pathophysiology is poorly understood and studies examining non‐European populations are lacking.Methods: In this study, NGRn BPH, normal prostate, and prostate cancer (PCa) tumor samples were sequenced and compared to characterize genetic alterations in NGRn BPH.Results: Two hundred and two nonbenign, ClinVar‐annotated germline variants were present in NGRn BPH samples. Six genes [BRCA1 (92%), HSD3B1 (85%), TP53 (37%), PMS2 (23%), BARD1 (20%), and BRCA2 (17%)] were altered in at least 10% of samples; however, compared to NGRn normal and tumor, the frequency of alterations in BPH samples showed no significant differences at the gene or variant level. BRCA2_rs11571831 and TP53_rs1042522 germline alterations had a statistically significant co‐occurrence interaction in BPH samples. In at least two BPH samples, 173 genes harbored somatic variants known to be clinically actionable. Three genes (COL18A1, KIF16B, and LRP1) showed a statistically significant (p < 0.05) higher frequency in BPH. NGRn BPH also had five gene pairs (PKD1/KIAA0100, PKHD1/PKD1, DNAH9/LRP1B, NWD1/DCHS2, and TCERG1/LMTK2) with statistically significant co‐occurring interactions. Two hundred and seventy‐nine genes contained novel somatic variants in NGRn BPH. Three genes (CABP1, FKBP1C, and RP11‐595B24.2) had a statistically significant (p < 0.05) higher alteration frequency in NGRn BPH and three were significantly higher in NGRn tumor (CACNA1A, DMKN, and CACNA2D2). Pairwise Fisher's exact tests showed 14 gene pairs with statistically significant (p < 0.05) interactions and four interactions approaching significance (p < 0.10). Mutational patterns in NGRn BPH were similar to COSMIC (Catalog of Somatic Mutations in Cancer) signatures associated with aging and dysfunctional DNA damage repair.Conclusions: NGRn BPH contained significant germline alteration interactions (BRCA2_rs11571831 and TP53_rs1042522) and increased somatic alteration frequencies (LMTK2, LRP1, COL18A1, CABP1, and FKBP1C) that impact apoptosis. Normal prostate development is maintained by balancing apoptotic and proliferative activity. Dysfunction in either mechanism can lead to abnormal prostate growth. This work is the first to examine genomic sequencing in NGRn BPH and provides data that fill known gaps in the understanding BPH and how it impacts men of African ancestry.